These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 8190146)

  • 21. [Early intervention in HIV infection].
    Gotić M; Rolović Z; Elezović I; Marisavljević D; Berger D
    Srp Arh Celok Lek; 1992 Nov; 120 Suppl 5():30-2. PubMed ID: 18170974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early therapeutic intervention in HIV infection--stepping stones to success.
    Weller IV
    Immunodefic Rev; 1991; 2(4):303-13. PubMed ID: 2059435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early zidovudine and survival in HIV infection.
    Hirschel B
    N Engl J Med; 1992 Sep; 327(11):814; author reply 815-6. PubMed ID: 1501667
    [No Abstract]   [Full Text] [Related]  

  • 24. Zidovudine in HIV infection.
    Drug Ther Bull; 1991 Oct; 29(21):81-2. PubMed ID: 1935595
    [No Abstract]   [Full Text] [Related]  

  • 25. Zidovudine for early HIV infection: yes, no, maybe.
    Roberts JC
    BMJ; 1993 Aug; 307(6900):346-7. PubMed ID: 8374414
    [No Abstract]   [Full Text] [Related]  

  • 26. [The progression of HIV infection slowed down. Studies with zidovudine--the blood picture changes].
    Biedermann-Hefner M
    Fortschr Med; 1990 Apr; 108(10):72. PubMed ID: 2341104
    [No Abstract]   [Full Text] [Related]  

  • 27. Primary care intervention and management for adults with early HIV infection.
    Santangelo J; Schnack J
    Nurse Pract; 1991 Jun; 16(6):9-10, 12, 15. PubMed ID: 1677748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Low doses of AZT: is it really a good option?].
    Calva JJ; Sierra-Madero JG
    Rev Invest Clin; 1993; 45(2):179-81. PubMed ID: 8337546
    [No Abstract]   [Full Text] [Related]  

  • 29. [Utilization of zidovudine in the early stage of HIV infection. Lower dosages lessen toxicity].
    Mahler W
    Fortschr Med; 1990 Oct; 108(31):87-8. PubMed ID: 2258132
    [No Abstract]   [Full Text] [Related]  

  • 30. Factors predictive of maternal-fetal transmission of HIV-1. Preliminary analysis of zidovudine given during pregnancy and/or delivery.
    Morrison JC
    Pediatr AIDS HIV Infect; 1995 Feb; 6(1):24-6. PubMed ID: 11361739
    [No Abstract]   [Full Text] [Related]  

  • 31. Evaluation of the quality of life associated with zidovudine treatment in asymptomatic human immunodeficiency virus infection. The AIDS Clinical Trials Group.
    Lenderking WR; Gelber RD; Cotton DJ; Cole BF; Goldhirsch A; Volberding PA; Testa MA
    N Engl J Med; 1994 Mar; 330(11):738-43. PubMed ID: 7906386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Soluble tumor necrosis factor receptors as surrogate markers for the assessment of zidovudine treatment in asymptomatic HIV-1 infection.
    Godfried MH; van der Poll T; Mulder JW; Weverling GJ; Endert E; Lange JM; Sauerwein HP
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(5):531-9. PubMed ID: 8548332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early zidovudine and survival in HIV infection. The Veterans Affairs AIDS Cooperative Studies Group.
    Hartigan PM; Hamilton JD; Simberkoff MS
    N Engl J Med; 1992 Sep; 327(11):814-5; author reply 815-6. PubMed ID: 1501668
    [No Abstract]   [Full Text] [Related]  

  • 34. AZT benefits HIV-positive asymptomatic people: new hope, new challenges.
    Lewis A
    AIDS Educ Prev; 1989; 1(4):347. PubMed ID: 2641256
    [No Abstract]   [Full Text] [Related]  

  • 35. [Virological monitoring in subjects with HIV infection under treatment with zidovudine (AZT)].
    Fiore JR; Angarano G; Fico C; Lo Caputo S; Fracasso C; Barile M; Pastore G
    Boll Soc Ital Biol Sper; 1990 Jun; 66(6):601-6. PubMed ID: 2124131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Zidovudine and human immunodeficiency virus infection: when and how to initiate treatment].
    Corzo JE; Leal M
    Med Clin (Barc); 1991 Jun; 97(5):178-80. PubMed ID: 1921546
    [No Abstract]   [Full Text] [Related]  

  • 37. Drug resistance mutations as predictors of phenotypic zidovudine resistance in HIV-1 infection.
    Chen P; Schmit JC; Arendt V; Plesseria JM; Lambert C; Fontaine E; Kirpach P; Ninove D; Schneider F; Hemmer R
    AIDS; 1997 Oct; 11(12):1528-9. PubMed ID: 9342081
    [No Abstract]   [Full Text] [Related]  

  • 38. [Impact of zidovudine treatment and the pneumocystis carinii prophylaxis in natural history of patients with HIV infection].
    Sáiz Hervas E; Castilla Castellano V; Miquel Plaza J; Benito Blanco AM; Martín Llorens MM; Pastor de Blas M; Izquierdo P; Muñoz Jareño MA; Sierra A; Nieto MA; Moreno Collado AM; Fraguas C
    An Med Interna; 1998 Mar; 15(3):132-7. PubMed ID: 9580410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of HIV infection with zidovudine. The good use of AZT].
    Régnier B
    Rev Prat; 1991 Sep; 41(19):1801-4. PubMed ID: 1925359
    [No Abstract]   [Full Text] [Related]  

  • 40. Should research ethics change at the border?
    McNeill PM
    Med J Aust; 1998 Nov; 169(10):509-10. PubMed ID: 9861904
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.